Gnubiotics Sciences

04/10/2021

Gnubiotics’ CEO Yemi Adesokan to present important new science at the 4th Animal Gut Health & Nutrition Summit on October 12-14. (https://animal-gut-health-summit.com/)

Yemi will talk about microbiome biomarkers predicting a number of diseases, such as obesity and chronic kidney disease and exciting nutritional solutions emerging to help these conditions.

Join Yemi at the Summit to learn more and visit https://gnubiotics.com/

06/08/2021

An increasing number of scientific publications such as the article below highlight the critical role mucine with its complex and diverse glycan structures plays in maintaining a healthy and strengthening our immune system.

Gnubiotics is at the forefront of this development and its first product, GNUbiome FI, has demonstrated to form, restore and maintain a healthy microbiome in companion .
Preclinical in human applications has also begun.

Contact Gnubiotics at [email protected] to learn more.

https://lnkd.in/dZHb6HRx

22/07/2021

We are delighted and humbled to be a part of the 2021 cohort of Venture Leaders Biotech Swtizerland.

Founded on proprietary pillars of microbiome innovation, Gnubiotics first diagnoses and defines microbiome health and disease conditions, then produces natural glycan based solutions to restore and maintain a healthy microbiome.

https://gnubiotics.com/

14/07/2021

We are very proud to represent Switzerland on a global scale at Venture Leader Biotech 2021.

Proud to present to you: the Swiss National Startup Team, representing Switzerland on a global scale! Meet the happy winners of Venture Leaders Biotech 2021:
https://www.venturelab.swiss/Venture-Leaders-Biotech-2021-10-new-Swiss-National-Startup-Team-members-to-showcase-Swiss-biotech-innovation-on-the-global-stage

Welcoming:

Acthera Therapeutics Ltd. | Carlo Bertozzi
www.venturelab.swiss/Acthera

Alithea Genomics | Riccardo Dainese,
www.venturelab.swiss/alithea

Avrion Therapeutics | Maximilien Murone
www.venturelab.swiss/avrion

cellvie | Alexander Schueller
www.venturelab.swiss/Cellvie

deepCDR Biologics | Simon Friedensohn
www.venturelab.swiss/deepcdr

Gnubiotics Sciences | Yemi Adesokan
www.venturelab.swiss/gnubiotics

HexagonFab | Christoph v. Bieberstein
www.venturelab.swiss/HexagonFab

Nemosia | Awa F. DIAGNE
www.venturelab.swiss/nemosia

NextImmune | Rajesh Jayachandran www.venturelab.swiss/NextImmune

STALICLA | Lynn-Allison Durham
www.venturelab.swiss/STALICLA

Venture Leaders Biotech 2021 is co-organized by Venturelab and Swissnex and supported by EPFL (École polytechnique fédérale de Lausanne), ETH Zürich, VISCHER, and Kanton Zürich.

18/05/2021

Proud to announce that we have notification on the allowance of our patent on microbiome markers for prediction and treatment of feline obesity by the European Patent Office.

This patent covers the prediction and identification of feline obesity based on the microbiome.

Following this patent, Gnubiotics will be launching REVELAbiome, a microbiome test that will include our patented biomarkers of obesity and leanness in cats.. REVELAbiome will empower pet owners to make personalized health and nutrition choices based on a simple and accurate assessment of their pet’s microbiome health status.

Gnubiotics Sciences differentiates itself through innovation and passion, which is why this recognition means so much to us.

17/05/2021

Next Tuesday the Annual Petcare Innovation Summit will begin. At this event we will focus on pet health, nutrition and obesity as the main issue.

Until then, let's start by asking a question ➡ ️ Are our lifestyle and nutritional habits related to our pet’s health?

Considering that pets and owners share the same space and time together, it should come as no surprise that they share some health problems related to their habits or lifestyle.

Undoubtedly, the current trend in processed foods affects both the human food industry and the diet of dogs and cats. This implies a high risk of developing diabetes, heart disease, autoimmune diseases and cancer, both in humans and pets.

14/05/2021

Among the most common diseases related to obesity in dogs and cats are joint diseases, such as osteoarthritis or those at the metabolic level, such as hypothyroidism. These diseases are known as concomitant, since they occur in the same period of time as obesity in pets. In addition, they can be the origin of obesity by causing them to move less.

Do you want to know more about this topic and the consequences of overweight in pets as a major current problem? ⤵

Join us at the 4th Annual Petcare Innovation Summit taking place 18-19 May, 2021.

13/05/2021

✅ Gnubiotics will be at the 4th Annual Pet Care Innovation Summit.

✅ Date: 18-19 May, 2021.

Dr. Yemi Adesokan, Chief Scientific Officer and Co-Founder of Gnubiotics Sciences, will lead an expert panel discussion entitled "Nutritional health in pets: what do they really need?".

This session will cover different issues within pet nutrition beyond popular trends: the role of biotechnology in the production of beneficial pet food, as well as supplements that improve pets' digestion.

12/05/2021

Over the last decade, dogs and cats have become increasingly overweight.

Obesity has serious health consequences for dogs and cats, as does the human obesity epidemic, plus it implies heavy budgetary costs.

Join us at the 4th Annual Petcare Innovation Summit, which will take place on 18-19 May, 2021.

The main topic of this event will revolve around pet nutrition:

➡️How important is it to know our pets’ microbiome?

➡️Should pet foods contain oligosaccharides?

➡️How can pets get the fiber they need?

➡️Are supplements needed if the pet is well fed?

23/03/2021

Remember!

Tomorrow starts the Animal Microbiome Congress 2021

A 100% online event specialized in animal microbiome where more than 30 experts from the sector will discuss the latest trends in the industry.

Join our CSO and co-founder, Yemi Adesokan, who will be leading a panel discussion on "Translating Animal Microbiome research from the laboratory to the field."

This is a must-see industry event where you can learn more about the animal microbiome, while building your network with the best professionals in the field.

So don't forget and register for this event now at:
https://animalmicrobiomecongress.com/events/animal-microbiome-congress-2021

18/03/2021

Gnubiotics Sciences is excited about unlocking the full functional potential of Animal Microbiome!

Do not hesitate and join us at the Animal Microbiome Congress powered by Kisaco Research.

This online event is the perfect opportunity to expand your network with the leading experts in the sector.

Do not miss our CSO and Co-Founder, Yemi Adesokan, who will lead a panel discussion on how animal microbiome solutions can be effective in increasing immunity and reducing the incidence and severity of conditions.

You can now register for this event at: https://animalmicrobiomecongress.com/events/animal-microbiome-congress-2021

15/03/2021

We are thrilled to announce a range of publications on our new class of molecules Animal Milk Oligosaccharides (AMOs).

Research done at Gnubiotics in partnership with UIUC promises to revolutionize the pet health industry in its most recent trend: the .

To find out more about the promise of AMOs click below.
https://aces.illinois.edu/news/milk-prebiotics-are-cats-meow-illinois-research-shows

Stay tuned for more for more news on AMOs research from Gnubiotics